Dr. Chavda is dedicated and highly motivated research scientist with more than 13 years of rich Industry-Academic experience. His area of interest is development of formulations including Oral solids, Liquids, Semi-solids, Parenterals and NDDS. He has developed stable and robust formulations across various dosage forms. He has sound understanding of formulation and development using QbD and DOE approaches. He has understanding of product development lifecycle, clinical and regulatory requirements of regulatory bodies like UKMHRA, USFDA etc. There are more than 35 International and National research publications to his credit. In addition to that he has several magazines related articles and Books publications. He is providing editorial service for international journals. He is serving as reviewer at Elsevier, Bentham Sciences, Informa Healthcare, and Wiley Journals.

List of publications:

1. Chavda HV*, Neerumalla S, Patel A, Poptani S. Excipients: The Real Players behind Robust

Formulation. Indian Journal of Pharmaceutical Education and Research. January 2019; 53(1):

5-7.

2. Chavda HV*. Artificial Neural Networks in Pharma Product Development. Chronicle

Pharmabiz. May 2018; 18(23): 42-43.

3. Chavda HV*. 3D printing: Upcoming revolution for pharmaceutical industry. Chronicle

Pharmabiz. April 2018; 18(21): 10.

4. Chavda HV*. Qbd in Developing Topical Dosage Forms. Elyns Journal of Pharmaceutical

Research December 2016; 2(1): 90000106. [Short Communication]

5. Chavda HV*. Nanopharmaceuticals: The Pharmaceuticals of Present Era. Elyns Journal of

Pharmaceutical Research 2016; 1(2): 106e. [Editorial Article]

6. Chavda HV*, Naik S, Mukhopadhyay P. QbD Concept Implementation for Excipients.

Ingredients South Asia Magazine. Saffron Media Publication, November, 2016; 11: 119-120.

7. Chavda HV*. Reforms in Pharmaceutical Education in India. Ingredients South Asia

Magazine. Saffron Media Publication, April 16-30, 2016; 9(14): 48-51.

8. Chavda HV*. African Market: Big Window of Opportunity. Ingredients South Asia Magazine.

Saffron Media Publication, January 16-31, 2016; 9(8): 30-32.

9. Chavda HV*. SPHs as an Unusual Upcoming Excipient. Ingredients South Asia Magazine.

Saffron Media Publication, December 1-15, 2015; 9(5): 104-111.

10. Chavda HV*, Patel RI, Patel CN. Preparation and Characterization of Ternary Solid Dispersion

of Flunarizine Dihydrochloride. World Journal of Pharmaceutical Research (ISSN: 2277-7105)

2015; 4(5): 2506-2521.

11. Chavda HV*, Chavada G, Patel J, Rangpadiya K, Patel CN. Topical Vaginal Drug Delivery

System Based on Superporous Hydrogel Hybrids. Protein & Peptide Letters (ISSN: 0929-8665,

Impact Factor 1.735) 2014; 21(11): 1176-1184.

12. Chavda HV*, Patel RD, Modhia IP, Patel CN. Role of Superporous Hydrogel Particles as a

Superdisintegrant in Fast Disintegrating Tablet of Glipizide. Chronicles of Young Scientists

(ISSN: 2229-5186) 2014; 5(1):11-19.

13. Chavda HV*, Patel J, Chavada G, Dave S, Patel A, Patel CN. Self Nanoemulsifying Powder of

Isotretinoin: Preparation and Characterization. Journal of Powder Technology. (ISSN: 2090-

7737) 2013; 2013 Article ID 108569, 9 pages. [Cited on 15/11/2013].

14. Chavda HV*, Modhia IP, Mehta A, Patel RD, Patel CN. Development of Bioadhesive Chitosan

Superporous Hydrogel Composite Particles based Intestinal Drug Delivery System. BioMed

Research International (ISSN: 2314-6133, Impact Factor 2.880) 2013; 2013 Article ID 563651,

10 pages. [Cited on 06/08/2013]

Page 7 of 12 Dr. Hitesh Chavda

15. Chavda HV*, Patel SK, Patel CN. Insignificant Effect of Superporous Hydrogel Particles as a

Superdisintegrants in Fast Dispersible Tablets of Aceclofenac. Online article PharmaTutor

(ISSN: 2347 - 7881) 2013 (Published on Web 31/01/2013). Available from:

http://www.pharmatutor.org/articles/ insignificant-effect-of-superporous-hydrogelparticles-

as-superdisintegrants-in-fast-dispersible-tablets-of-aceclofenac?page=0,0 [Cited on

31/01/2013].

16. Chavda HV*, Patel RD, Modhia IP, Patel CN. Preparation and Characterization of

Superporous Hydrogel Based on Different Polymers. Int J Pharm Investig (ISSN: 2230-973X)

2012; 2(3):134-139.

17. Chavda HV*, Patel MS, Patel CN. Preparation and In Vitro Evaluation of Guar Gum Based

Triple-Layer Matrix Tablet of Diclofenac Sodium. Res Pharm Sci (ISSN: 1735-5362, Impact

Factor 0.220) 2012; 7(1): 57-64.

18. Chavda HV*, Patel CN. Pharmaceutical Formulations for Oral Transmucosal Drug Delivery.

News Tech 2011; 29:10-11.

19. Chavda HV*, Patel CN, Modh KM, Panigrahi B. Preparation, Characterization and In Vitro

Evaluation of Carbopol-based Superporous Hydrogel Composite. Indian J Pharm Sci (ISSN:

0250-474X, Impact Factor: 0.626) 2011; [Accepted on 12/05/2011].

20. Chavda HV*, Chaudhari TM, Patel CN. Antacids Incorporation in Immediate Release Tablets

Failed to Improve the Stability of Omeprazole in Acidic Media. J Pharm Negative Results

(ISSN: 0976-9234) 2011; 2(2):73-77.

21. Chavda HV*, Patel CN. Preparation and in vitro evaluation of a stomach specific drug delivery

system based on superporous hydrogel composite. Indian J Pharm Sci (ISSN: 0250-474X,

Impact Factor: 0.626) 2011; 73(1):30-37.

22. Chavda HV*, Patel CN. Effect of Crosslinker Concentration on Characteristics of Superporous

Hydrogel. Int J Pharm Investig (ISSN: 2230-973X) 2011; 1(1):17-21.

23. Chavda HV*, Patel CN. A Newer Formulation Approach: Superporous Hydrogel Composite-

Based Bioadhesive Drug-Delivery System. Asian J Pharm Sci (ISSN: 1818-0876, Impact Factor

0.250) 2010; 5(6): 239-250.

24. Chavda HV*, Patel CN. Chitosan Superporous Hydrogel Composite-Based Floating Drug-

Delivery System: A Newer Formulation Approach. J Pharm Bioall Sci (ISSN: 0976-4879,

Impact Factor 0.175) 2010; 2(2): 124-131.

25. Chavda HV*, Patel CN, Prajapati ST, Patel CV. A Newer Formulation Approach Based on

Superporous Hydrogel Particles for Gastroretentive Drug-Delivery System: Preparation and

In Vitro Evaluation. Inventi Impact: NDDS (ISSN: 2229-4147) 2010; 2: Article ID: 2010nd70a

(Published on Web 15/07/2010; www.inventi.in).

26. Chavda HV*, Patel CN, Prajapati ST, Patel CV. A Newer Formulation Approach Based on

Superporous Hydrogel Particles for Gastroretentive Drug-Delivery System: Preparation and

In Vitro Evaluation. Inventi Rapid: NDDS (e-ISSN: 0976-3791) 2010; 1(1): Article ID:

2010nd70a (Published on Web 13/04/2010; www.inventi.in).

27. Chavda HV*, Patel CN, Anand IS. Biopharmaceutics Classification System. Syst Rev Pharm

(ISSN: 0975-8453) 2010; 1(1): 62-69.

28. Chavda HV*, Patel CN. Preparation and Characterization of Swellable Polymer-based

Superporous Hydrogel Composite of Poly (Acrylamide-co-Acrylic Acid). Trends Biomater Artif

Organs (ISSN: 0971-1198, Impact Factor: 0.675) 2010; 24(2): 83-89.

29. Chavda HV*, Patel CN. Effects of Solvent Treatments on Characteristics of Superporous

Hydrogels. Ethiopian Pharm J (ISSN: 1029-5933) 2009; 27(1): 16-24.

30. Chavda HV*, Patel CN, Karen HD. Preparation and Characterization of Chitosan-Based

Superporous Hydrogel Composite. J Young Pharm (ISSN: 0975-1483) 2009; 1(3): 199-204.

31. Chavda HV*, Patel CN. Aquaporins: Secret Highways for Water Transport. Pharm Reviews

(ISSN: 1918-5561) 6(2), Apr 11, 2008.

Page 8 of 12 Dr. Hitesh Chavda

32. Chavda HV*, Patel CN, Patel AM, Patel BN. Supercritical Fluid: Green Solvent for Tomorrow.

Pharm Reviews (ISSN: 1918-5561)5(3), May 16, 2007.

33. Chavda HV*. Dendrimers: Polymers of 21st Century. Pharm Reviews (ISSN: 1918-5561) 5(1),

Feb. 02, 2007.

Co-author:

34. Modi J*, Patel JK, Chavda HV. Superporous Hydrogel: A Supreme Approach for Gastric

Retention. Online article PharmaTutor (ISSN: 2347 - 7881) 2012 (Published on Web

03/08/2012). Available from: http://www.pharmatutor.org/articles/superporous-hydrogela-

supreme-approach-for-gastric-retention [Cited on 31/01/2013].

35. Karen HD*, Anand IS, Patel CN, Chavda HV, Patel JK. Formulation and Evaluation of

Amphotericin-B as A Lyophilized Product. J Global Pharma Tech (ISSN: 0975-8542) 2010;

2(2): 75-78.

36. Parikh BN*, Gothi GD, Patel TD, Chavda HV, Patel CN. Microsponge as Novel Topical Drug

Delivery System. J Global Pharma Tech (ISSN: 0975-8542) 2010; 2(1): 17-29.

Research Interest: Organic Chemistry: Total Synthesis of Complex Natural Product, Computational Chemistry: Conformational Analysis, Molecular Modelling and Spectra Simulation. Natural Product Discovery: Isolation, Structural Elucidation, and Absolute Configuration Deter-mination of Natural Product.

Mehraliyeva Sevil Jabrayil graduated from the Faculty of Pharmacy of Azerbaijan State Medical Institute named after N.Narimanov in 1989 with honors diploma. was elected to the position and is currently working in this position.

 In 2010, S.J.Mehraliyeva defended her dissertation on the topic "Development of the technology for obtaining medicinal forms from some multicomponent plant assemblies and studying their biopharmaceutical properties", in 2011 she received the diploma of Doctor of Philosophy in Pharmacy, and in 2014 she received the scientific title of associate professor.

 Sevil Mehraliyeva is a member of the "Problem Commission on Pharmacy and Chemistry", 224156-Specialized Council for master's defense in "Pharmaceutical technology". He participated in the congresses held in 2020-2022, including training on Good Clinical Practice and received a certificate. In February 2022, he completed an internship at DAYTAM, Atatürk University of the Republic of Turkey.

Sevil Mehraliyeva made oral presentations at conferences held in the Republics of Azerbaijan, Russia, and Turkey during the period of her scientific research and was awarded certificates.

For the first time, Sevil Mehraliyeva developed immunotropic granules based on various phytocompositions, dental gel with anti-aging effect, anti-aging cream, anti-seborrheic shampoo, microcapsules for the treatment of atherosclerosis, anti-acne niosomal gel technology, and was awarded Azerbaijan and Eurasian patents (2017). -2022).

Since 2020, Mehraliyeva Sevil Jabrail has been working on her doctoral dissertation on the topic "Development of technology for obtaining nano-forms of medicine based on raw materials of natural origin".

According to the subject of his doctoral dissertation, he developed the technology of extraction from deer antlers grown in Azerbaijan for the first time. The technology of obtaining nanocapsules for the treatment of Alzheimer's, nanoemulsion and nanogel for the treatment of osteoporosis on the basis of this extract and the acquisition of an Azerbaijani patent in this field belong to Sevil Mehraliyeva (2021-2024).

In 2023-24, Sevil Mehraliyeva carried out the method of separating the actinide enzyme, which accelerates the digestion process, from the Chinese actinidia fruits grown in Azerbaijan and the microencapsulation of this enzyme.

Sevil Mehraliyeva also performed the technology of separating rutin from Japanese sophora buds and hop cones and preparing phytosomes based on rutin. Based on these phytosomes, the preparation of phytosomal gel with an effective effect in the treatment of periodontitis and the study of quality criteria were performed by Sevil Mehraliyeva (2024).

Research Interests: pharmaceutical technology, phyto- and animal medicinal technology, nanotechnology, nanocosmetology, nano- and micropharmaceutical medicinals, biopolymer technology, new drug delivery systems, including stomatological drug delivery systems.

Research Interest: Reactive Oxygen Species, Apoptosis, Signaling Pathways, Western Blot, Phosphorylation, Superoxide Dismutase, NADPH Oxidase, Monocytes

Research Interest: Medicinal Plants, Obtaining, Characterization and standardization of extracts, Testing their pharmacological Action, Testing antioxidant activity in vitro and in vivo, Analysis and  isolation of biologically active compounds (polyphenols, carotenoides, essential oils, terpenes, alkaloids), spectrometric and chromatographical analysis (HPLC, GC).

Research Interest: Nanomedicines for therapy Parkinson's disease, Alzheimer’s disease and neural Tissue repair.

Research Interest: Method development and validation of biosensors for estimation of Cancer Markers.

Research Interest: Antioxidants and free radicals, Cardiovascular Pharmacology, Behavioral tests, Cell culture and cancer research, Pulmonary Pharmacology.

Research Interest: Microbiology and Immunology, Antibiotic mechanism of Action and resistance, Inflammation and Natural Antiinflamatory Products.

Research Interest: Natural drug discovery, Isolation, Physiological and pharmacological characterization of venom/toxin peptides and proteinswith animal tissues, Natural peptides and proteins analytical Chemistry, Mass spectrometry analysis, Molecular biology, Synthetic peptide analogues and their interaction with antibodies and receptors, Identification of novel drug targets, Biomarkers, Ion channel.

Research Interest: Drug Delivery, Continuous manufacturing, Dissolutions, Solubility, Cocrystalisation, Hot-Melt Extrusion, Particle Engineering, Medical Implants, Solid-State Analysis, PAT, QbD, Spray Drying, Process Engineering.

Research Interest: Epidemiology, Health Management and Rheumatology.

Research Interest: Pharmacology & Toxicology, Experimental Pharmacology, Toxicology.

Research Interest: G-protein coupled receptors for lipid mediators, Molecular and cellular functions of lipid mediators.

Research Interest: Bioactive constituents from natural resources, Quality control methods of natural medicines, Anaphylactoid constituents of herbal injections, R&D of new natural medicines.